Related references
Note: Only part of the references are listed.No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2011)
Variability in on-treatment platelet reactivity explained by CYP2C19*2 genotype is modest in clopidogrel pretreated patients undergoing coronary stenting
Heleen J. Bouman et al.
HEART (2011)
Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel The Importance of CYP2C19*2 Genotyping
Dimitrios Alexopoulos et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
R. Scott Wright et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Prospective Evaluation of On-Clopidogrel Platelet Reactivity Over Time in Patients Treated With Percutaneous Coronary Intervention Relationship With Gene Polymorphisms and Clinical Outcome
Gianluca Campo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Relationship between paraoxonase-1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE study
P. Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Paraoxonase-1 is a major determinant of clopidogrel efficacy
Heleen J. Bouman et al.
NATURE MEDICINE (2011)
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel Results from PRINCIPLE-TIMI 44
Andrew L. Frelinger et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: Systematic review and meta-analysis
Daniel Aradi et al.
AMERICAN HEART JOURNAL (2010)
Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies The RESPOND Study
Paul A. Gurbel et al.
CIRCULATION (2010)
Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
Dirk Sibbing et al.
CIRCULATION (2010)
Acceptance of High Platelet Reactivity as a Risk Factor
Paul A. Gurbel et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI A Meta-analysis
Jessica L. Mega et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation
Nicoline J. Breet et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Platelet Aggregation and Its Association With Stent Thrombosis and Bleeding in Clopidogrel-Treated Patients Initial Evidence of a Therapeutic Window
Dirk Sibbing et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis
J. M. Siller-Matula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis
Jessica L. Mega et al.
LANCET (2010)
Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
Lars Wallentin et al.
LANCET (2010)
Low platelet disaggregation predicts poor response to 150 mg clopidogrel in patients with elevated platelet reactivity
Daniel Aradi et al.
PLATELETS (2010)
Clopidogrel non-responsiveness and risk of cardiovascular morbidity An updated meta-analysis
Francesco Sofi et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment
Isabell Bernlochner et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Association of platelet responsiveness with clopidogrel metabolism: Role of compliance in the assessment of resistance
Victor Serebruany et al.
AMERICAN HEART JOURNAL (2009)
Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention Results From the Double-Blind, Prospective, Randomized Tailoring Treatment With Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel Study
Marco Valgimigli et al.
CIRCULATION (2009)
Personalized medicine and antiplatelet therapy: ready for prime time?
Celine Verstuyft et al.
EUROPEAN HEART JOURNAL (2009)
Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
Alan R. Shuldiner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events.
Tabassome Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: A multicenter randomized prospective study
Laurent Bonello et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Impact of P-glycoprotein on clopidogrel absorption
Dirk Taubert et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Platelet reactivity in patients and recurrent events post-stenting - Results of the PREPARE POST-STENTlNG study
PA Gurbel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
ESC guidelines for percutaneous coronary interventions: reply
S Silber
EUROPEAN HEART JOURNAL (2005)
Variability in platelet responsiveness to clopidogrel among 544 individuals
VL Serebruany et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
The difference between clopidogrel responsiveness and posttreatment platelet reactivity
WM Samara et al.
THROMBOSIS RESEARCH (2005)
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction
S Matetzky et al.
CIRCULATION (2004)
Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation
P Barragan et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2003)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Individual variations of platelet inhibition after loading doses of clopidogrel
P Järemo et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Share Paper
